País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
PARACETAMOL
Aziende Chimiche Riunite Angelini Francesco
PARACETAMOL
1000 Milligram
Tablets
Product not subject to medical prescription
Authorised
0000-00-00
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol Max 1000 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 1000 mg of paracetamol For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. White to slightly yellow oblong tablets with smooth surface and a central break line. The tablet can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of mild to moderate pain (such as headache, migraine, toothache, sore throat, backache, muscle pain, rheumatic pain, dysmenorrhoea) and/or fever. Paracetamol Max 1000 mg Tablets is indicated in adults and adolescents aged 16 years and over, whose body weight is greater than 50 kg. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Doses depend on body weight and age with a maximum of 60 mg/kg body weight for total daily dose, not exceeding 4000 mg daily. Adults and adolescents over 16 years of age and >50 kg of body weight: One tablet to be taken four times a day as required. Paracetamol Max 1000 mg Tablets should not be given more frequently than every 4-6 hours, and not more than 4 doses (4000 mg) should be given in any 24 hour period. Not to be given to children under 16 years of age. Renal insufficiency In case of renal insufficiency the dose should be reduced: Hepatic insufficiency In patients with impaired hepatic or Gilbert’s syndrome, the dose must be reduced or the dosing interval prolonged. GLOMERULAR FLITRATION RATE DOSE 10-50 ml/min 500 mg every 6 hours < 10 ml/min 500 mg every 8 hours IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 25/11/2013_ _CRN 2138859_ _page number: 1_ The daily effective dose should Leer el documento completo